-
Ischemic cardiomyopathy remains a frequent cause of heart failure. Management of patients with coronary artery disease with LV dysfunction has traditionally been achieved with coronary artery bypass graft surgery (CABG). More recently, percutaneous coronary intervention (PCI) has shown similar results to CABG in patients with multi-vessel coronary artery disease.
-
In this study, Sacher and colleagues, from three well-know ablation centers, report their experience with epicardial ventricular tachycardia (VT) ablation.
-
Ambulatory cardiac telemetry uses a cellular phone monitor to continuously receive transmissions from a sensor on the patient, interpret them, and send ECG strips, considered to be possibly dangerous arrhythmias, to a central station for review and possible intervention.
-
-
New reports about proton pump inhibitors and the effects of gastric suppression, pioglitazone vs vitamin E for non-alcoholic steatohepatitis, metformin and vitamin B12 deficiency, and FDA Actions
-
The optimal timing of cardiac catheterization for patients suffering non-ST segment elevation myocardial infarction (nonSTEMI) remains a subject of debate.
-
The use of angiotensin converting enzyme (ACE) inhibitors in all acute myocardial infarction (MI) patients is controversial.
-
Little is known about the long-term prognosis of the no-reflow phenomenon after percutaneous intervention (PCI) for acute ST elevation myocardial infarction (STEMI).
-
Dronedarone is an antiarrhythmic drug with structural and electrophysiologic similarities to amiodarone that was released in 2009. Dronedarone's structure includes a benzofuranyl ring but, unlike amiodarone, the ring is not iodinated.
-
